Targeted therapy and hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma in pediatric and adolescent patients: a pilot protocol results

Background. Introduction a targeted drugs in a real clinical practice bring a vast improvement of prognosis in patients with relapsed and refractory (r/r) Hodgkin lymphoma (HL). But it is necessary to increase the experience in anti-CD30 monoclonal antibodies in combination with second-line chemothe...

Full description

Bibliographic Details
Main Authors: Natalia S. Tsaplina, Timur T. Valiev, Kirill I. Kirgizov, Svetlana R. Varfolomeeva
Format: Article
Language:Russian
Published: IP Habib O.N. 2023-05-01
Series:Современная онкология
Subjects:
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/271831/pdf